AP1223A - Use of thiazolidinediones for the treatment of hyperglycaemia. - Google Patents

Use of thiazolidinediones for the treatment of hyperglycaemia. Download PDF

Info

Publication number: AP1223A
Authority: AP; ARIPO
Prior art keywords: insulin sensitiser; glucose levels; insulin; range; hyperglycaemia
Prior art date: 1997-10-13

Application number

APAP/P/2000/001788A

Other languages

English (en)

Other versions

AP2000001788A0 (en

Inventor

Robin Edwin Buckingham

Stephen Alistair Smith

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-13

Filing date

1998-10-12

Publication date

2003-11-13

1998-10-12 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-06-30 Publication of AP2000001788A0 publication Critical patent/AP2000001788A0/xx

2003-11-13 Application granted granted Critical

2003-11-13 Publication of AP1223A publication Critical patent/AP1223A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

APAP/P/2000/001788A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia. AP1223A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9721692.3A GB9721692D0 (en)	1997-10-13	1997-10-13	Novel treatment
PCT/GB1998/003067 WO1999018944A1 (en)	1997-10-13	1998-10-12	Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (2)

Publication Number	Publication Date
AP2000001788A0 AP2000001788A0 (en)	2000-06-30
AP1223A true AP1223A (en)	2003-11-13

Family

ID=10820481

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/2000/001788A AP1223A (en)	1997-10-13	1998-10-12	Use of thiazolidinediones for the treatment of hyperglycaemia.

Country Status (24)

Country	Link
EP (1)	EP1023057A1 (tr)
JP (1)	JP2001519383A (tr)
KR (1)	KR20010024482A (tr)
CN (1)	CN1281358A (tr)
AP (1)	AP1223A (tr)
AU (1)	AU9547198A (tr)
BG (1)	BG104405A (tr)
BR (1)	BR9815220A (tr)
CA (1)	CA2305289A1 (tr)
CZ (1)	CZ20001298A3 (tr)
EA (1)	EA200000418A1 (tr)
GB (1)	GB9721692D0 (tr)
HR (1)	HRP20000256A2 (tr)
HU (1)	HUP0003673A3 (tr)
ID (1)	ID24439A (tr)
IL (1)	IL135515A0 (tr)
NO (1)	NO20001897L (tr)
OA (1)	OA11519A (tr)
PL (1)	PL339804A1 (tr)
SK (1)	SK5322000A3 (tr)
TR (1)	TR200000957T2 (tr)
UA (1)	UA66809C2 (tr)
WO (1)	WO1999018944A1 (tr)
YU (1)	YU28700A (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL140664A0 (en) *	1998-07-21	2002-02-10	Smithkline Beecham Plc	Use of glucose uptake enhancer for reducing apoptosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994005659A1 (en) *	1992-09-05	1994-03-17	Smithkline Beecham Plc	Substituted thiazolidinedione derivatives
US5478852A (en) *	1993-09-15	1995-12-26	Sankyo Company, Limited	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE186724T1 (de) *	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate

1997
- 1997-10-13 GB GBGB9721692.3A patent/GB9721692D0/en not_active Ceased
1998
- 1998-10-12 WO PCT/GB1998/003067 patent/WO1999018944A1/en not_active Application Discontinuation
- 1998-10-12 UA UA2000042049A patent/UA66809C2/uk unknown
- 1998-10-12 IL IL13551598A patent/IL135515A0/xx unknown
- 1998-10-12 KR KR1020007003935A patent/KR20010024482A/ko not_active Application Discontinuation
- 1998-10-12 HU HU0003673A patent/HUP0003673A3/hu unknown
- 1998-10-12 OA OA1200000107A patent/OA11519A/en unknown
- 1998-10-12 ID IDW20000670A patent/ID24439A/id unknown
- 1998-10-12 PL PL98339804A patent/PL339804A1/xx unknown
- 1998-10-12 CN CN98812016A patent/CN1281358A/zh active Pending
- 1998-10-12 CZ CZ20001298A patent/CZ20001298A3/cs unknown
- 1998-10-12 BR BR9815220-3A patent/BR9815220A/pt not_active Application Discontinuation
- 1998-10-12 TR TR2000/00957T patent/TR200000957T2/tr unknown
- 1998-10-12 AU AU95471/98A patent/AU9547198A/en not_active Abandoned
- 1998-10-12 EA EA200000418A patent/EA200000418A1/ru unknown
- 1998-10-12 AP APAP/P/2000/001788A patent/AP1223A/en active
- 1998-10-12 JP JP2000515579A patent/JP2001519383A/ja active Pending
- 1998-10-12 SK SK532-2000A patent/SK5322000A3/sk unknown
- 1998-10-12 YU YU28700A patent/YU28700A/sh unknown
- 1998-10-12 EP EP98949088A patent/EP1023057A1/en not_active Withdrawn
- 1998-10-12 CA CA002305289A patent/CA2305289A1/en not_active Abandoned
2000
- 2000-04-12 NO NO20001897A patent/NO20001897L/no not_active Application Discontinuation
- 2000-05-02 HR HR20000256A patent/HRP20000256A2/hr not_active Application Discontinuation
- 2000-05-05 BG BG104405A patent/BG104405A/xx unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994005659A1 (en) *	1992-09-05	1994-03-17	Smithkline Beecham Plc	Substituted thiazolidinedione derivatives
US5478852A (en) *	1993-09-15	1995-12-26	Sankyo Company, Limited	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5478852C1 (en) *	1993-09-15	2001-03-13	Sankyo Co	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number	Publication date
SK5322000A3 (en)	2000-09-12
CZ20001298A3 (cs)	2001-08-15
GB9721692D0 (en)	1997-12-10
UA66809C2 (uk)	2004-06-15
IL135515A0 (en)	2001-05-20
WO1999018944A1 (en)	1999-04-22
OA11519A (en)	2004-02-09
ID24439A (id)	2000-07-20
HUP0003673A3 (en)	2001-12-28
TR200000957T2 (tr)	2000-08-21
CN1281358A (zh)	2001-01-24
CA2305289A1 (en)	1999-04-22
AP2000001788A0 (en)	2000-06-30
YU28700A (sh)	2003-10-31
BG104405A (en)	2000-12-29
KR20010024482A (ko)	2001-03-26
EP1023057A1 (en)	2000-08-02
NO20001897L (no)	2000-06-09
PL339804A1 (en)	2001-01-02
HRP20000256A2 (en)	2000-12-31
HUP0003673A2 (hu)	2001-10-28
NO20001897D0 (no)	2000-04-12
JP2001519383A (ja)	2001-10-23
EA200000418A1 (ru)	2000-10-30
BR9815220A (pt)	2000-11-14
AU9547198A (en)	1999-05-03

Publication	Publication Date	Title
AP1279A (en)	2004-05-20	Treatment of diabetes with thiazolidinedione and metformin.
AP1352A (en)	2004-12-24	Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide.
JP2005247865A (ja)	2005-09-15	チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
AP1223A (en)	2003-11-13	Use of thiazolidinediones for the treatment of hyperglycaemia.
AU8449098A (en)	1999-02-10	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
SK179499A3 (en)	2000-11-07	The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent
OA11510A (en)	2004-02-03	Treatment of diabetes with thiazolidinedione and sulphonylurea.
US20020006939A1 (en)	2002-01-17	Use of thiazolidinediones for the treatment of hyperglycaemia
US20020082284A1 (en)	2002-06-27	Use of thiazolidinediones for the treatment of hyperglycaemia
AU9547098A (en)	1999-05-03	Use of thiazolidinediones for the treatment of hyperglycaemia
AU4586902A (en)	2002-08-01	Use of thiazolidinediones for the treatment of hyperglycaemia
AU4587002A (en)	2002-08-01	Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA00003634A (en)	2001-05-07	Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA00003633A (en)	2001-07-31	Use of thiazolidinediones for the treatment of hyperglycaemia
WO2001047520A1 (en)	2001-07-05	Thiazolidinedione derivatives in treatment of diabetes mellitus of type 2
AU1011902A (en)	2002-03-07	Treatment of diabetes with thiazolidinedione and metformin